Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/22852
Title: Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives
Authors: Danilenko, L. M.
Keywords: medicine
pharmacology
meldonium
doxorubicin cardiopathy
isolated rat heart
doxorubicin-associated cardiomyopathy
Issue Date: 2018
Citation: Danilenko, L.M. Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives / L.M. Danilenko // Research result: pharmacology and clinical pharmacology. - 2018. - №4(1).- P. 81-86. - DOI: 10.3897/rrpharmacology. 4.25530.
Abstract: The cardioprotective effect of the derivatives (nicotinate, 5-hydroxynicotinate) of 3-(2,2,2-trimethylhydrazini- um) propionate) and reference medicine meldonium in the case of doxorubicin (DOX) (20 mg/kg, intraperitoneally for 48 hours) cardiomyopathy was evaluated by the results of a functional test with high-frequency stimulation (480 bpm)
URI: http://dspace.bsu.edu.ru/handle/123456789/22852
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Danilenko_Doxorubicin_18.pdf545.04 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.